These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 30482685
1. Inappropriate Shock Due to Myopotential Oversensing in a Patient With Subcutaneous Implantable Cardioverter-Defibrillator. Alasti M, Machado C, Kotschet E, Alison J. Heart Lung Circ; 2019 Apr; 28(4):e88-e90. PubMed ID: 30482685 [No Abstract] [Full Text] [Related]
2. Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD. Corzani A, Ziacchi M, Biffi M, Diemberger I, Martignani C, Boriani G. Indian Heart J; 2015 Apr; 67(1):56-9. PubMed ID: 25820052 [Abstract] [Full Text] [Related]
3. Surface electromyography of myopotential oversensing provoked by simultaneous straining and leftward twisting in a patient with an implantable cardioverter defibrillator. Ajiro Y, Shiga T, Shoda M, Hagiwara N. Heart Vessels; 2017 Mar; 32(3):364-368. PubMed ID: 27576324 [Abstract] [Full Text] [Related]
4. Myopotential Oversensing Is a Major Cause of Inappropriate Shock in Subcutaneous Implantable Defibrillator in Japan. Tsutsui K, Kato R, Asano S, Ikeda Y, Mori H, Tawara M, Tanaka S, Hasegawa S, Nakano S, Iwanaga S, Muramatsu T, Matsumoto K. Int Heart J; 2020 Sep 29; 61(5):913-921. PubMed ID: 32921668 [Abstract] [Full Text] [Related]
5. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient. Sasaki T, Nakamura K, Naito S. Int Heart J; 2019 Mar 20; 60(2):466-469. PubMed ID: 30745542 [Abstract] [Full Text] [Related]
7. Myopotential sensing by a dual chamber implantable cardioverter defibrillator: two case reports. Deshmukh P, Anderson K. J Cardiovasc Electrophysiol; 1998 Jul 20; 9(7):767-72. PubMed ID: 9684725 [Abstract] [Full Text] [Related]
8. Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator. Theuns DAMJ, Brouwer TF, Jones PW, Allavatam V, Donnelley S, Auricchio A, Knops RE, Burke MC. Heart Rhythm; 2018 Oct 20; 15(10):1515-1522. PubMed ID: 29758404 [Abstract] [Full Text] [Related]
9. Incidence of myopotential induction in subcutaneous implantable cardioverter-defibrillator patients: Is the oversensing issue really solved? van den Bruck JH, Sultan A, Plenge T, Seuthe K, Mödder T, Iliadis C, Stern D, Blankenheim T, Steven D, Lüker J. Heart Rhythm; 2019 Oct 20; 16(10):1523-1530. PubMed ID: 31048064 [Abstract] [Full Text] [Related]
13. Inappropriate shocks in a patient treated with a cardioverter defibrillator. Hutse W, Tavernier R, Jordaens L. Heart; 1997 Apr 20; 77(4):386-7. PubMed ID: 9155627 [No Abstract] [Full Text] [Related]
14. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator. Kelly PA, Mann DE, Damle RS, Reiter MJ. J Am Coll Cardiol; 1994 Jun 20; 23(7):1531-4. PubMed ID: 8195509 [Abstract] [Full Text] [Related]
15. Inappropriate discharge by an implantable cardioverter defibrillator: recognition of myopotential sensing using telemetered intracardiac electrograms. Sandler MJ, Kutalek SP. Pacing Clin Electrophysiol; 1994 Apr 20; 17(4 Pt 1):665-71. PubMed ID: 7516548 [Abstract] [Full Text] [Related]
20. Death due to an implantable cardioverter defibrillator. Messali A, Thomas O, Chauvin M, Coumel P, Leenhardt A. J Cardiovasc Electrophysiol; 2004 Aug 20; 15(8):953-6. PubMed ID: 15333095 [Abstract] [Full Text] [Related] Page: [Next] [New Search]